Mar 22 | Mar 21 | Mar 20 | Mar 19 | Mar 16 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 13.06M | $ 7.53M | $ 14.74M | $ 5.26M | $ 6.40M |
Total Assets | $ 272.14M | $ 237.89M | $ 258.03M | $ 276.54M | $ 230.91M |
Total Debt | $ 146.60M | $ 116.12M | $ 141.12M | $ 88.83M | $ 52.26M |
Net Debt | $ 133.53M | $ 108.59M | $ 126.37M | $ 83.58M | $ 45.85M |
Total Liabilities | $ 186.61M | $ 153.84M | $ 181.19M | $ 126.22M | $ 82.28M |
Stockholders Equity | $ 85.53M | $ 84.05M | $ 76.84M | $ 150.32M | $ 148.63M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |